ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 215721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 215721; 2) Community: the network communities that were significantly associated with the response to NSC 215721; 3) Molecule: the relationships between components within communities and NSC 215721; 4) MDR: the compounds that were significantly associated with the NSC 215721.

NSC Compound Enrichment Correlation
NSC 158036 1,2-Benzisothiazoline-3-thione, 2-methyl- (8CI) 0.0162638908166157 0.18793172
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.0162638908166157 0.17461676
NSC 633782 Simvastatin 0.0162638908166157 -0.044972272
NSC 635438 Null 0.0162638908166157 0.20916207
NSC 638643 3-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 0.0162638908166157 0.22206796
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.0162638908166157 0.23844778
NSC 668600 Null 0.0162638908166157 0.11743378
NSC 674278 Null 0.0162638908166157 -0.11908568
NSC 699427 Null 0.0162638908166157 0.15565521
NSC 754824 4-[4-(3-Methoxy-phenyl)-piperazin-1 -yl]-5H-pyrrolo[3,2-d]pyrimidine 0.0162638908166157 0.2319329
Total:76  Current:26    [First] [Prev] [Next] [Last]